Assessing the Options for Advanced Renal Cell Carcinoma
Released On
September 29, 2022
Expires On
September 28, 2023
Media Type
Internet
Completion Time
60 minutes
Specialty
Radiology, Hematology-Oncology,
Topic(s)
Renal Cell Carcinoma
This activity is provided by Practicing Clinicians Exchange.
This activity is supported by an educational grant from Merck Sharp & Dohme Corp.
Credit Available
- Physicians Assistants — maximum of 1.00 hours of AAPA Category 1 CME credits
- Nurses — 1.00 Nursing contact hours, includes 1.00 hour of pharmacology credit
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
Oncology NPs, PAs, and nurses
Program Overview
In recent years there has been a shift in preferred first-line treatment options for advanced renal cell carcinoma (RCC), with emphasis now placed on combinations of targeted and immunotherapies, making treatment decisions and sequencing options for patients more complex. This activity provides expert advice on how to select preferred treatment regimens for individual patients with RCC, as well as manage treatment-related adverse events (AEs) to provide optimal care.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Identify guideline-recommended first- and subsequent-line treatment options for advanced RCC
- Differentiate AEs associated with VEGFR TKIs from those associated with immune checkpoint inhibitors (irAEs)
- Utilize recommended monitoring and management strategies for AEs/irAEs in patients with RCC
Faculty
Cristina Salabao, MSN, FNP-C, AOCNP
Nurse Practitioner
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
Kathleen Madden, MSN
Nurse Practitioner
Melanoma Program
Perlmutter Cancer Center
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team
ANCC Credit Designation
Nursing contact hours:
1.00, which includes 1.00 hours of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until September 28, 2023. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Jessica Garner, DMSc, PA-C, University of the Pacific, Sacramento, California
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credits for learning and change.
Disclosures of Conflicts of Interest
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Cristina Salabao, MSN, FNP-C, AOCNP has no relevant financial relationships to disclose.Kathleen Madden, FNP, MSN, AOCNP, APHN: consultant/advisor/speaker: Novartis.
None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose, except Kathleen Madden, FNP, MSN, AOCNP, APHN, as noted above.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete evaluation form
The estimated time to complete this activity is 1.00 hour.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Practicing Clinicians requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please visit: https://practicingclinicians.com/customersupport.